Cardiovascular Disease· Topic 2.5 Congenital heart disease in adults· 2.5.3

Bicuspid aortic valve

Bicuspid aortic valve is the most common congenital heart defect, driving early degenerative valve disease and a distinct aortopathy independent of valve function; management tracks the predominant lesion (stenosis or regurgitation) plus lifelong surveillance of the ascending aorta with defined surgical thresholds.

9 min read3 practice questions7 key factsSubscriber article
  • Topic review
    The full article, organized the way the exam asks it.
  • ABIM-format MCQs
    Vignettes with an explanation for every wrong answer.
  • Key facts
    The numbers and thresholds worth memorizing, up front.
  • AI tutor
    MedBrain answers the question you're stuck on.

What this article covers

  • Overview

    Bicuspid aortic valve (BAV) is the most common congenital heart defect, in which the aortic valve forms with two functional cusps instead of three, with abnormal shear forces predisposing the leaflets to early fibrosis and calcification.

  • Epidemiology

    Affects approximately 1% to 2% of the general population, the most common congenital heart defect, inherited in an autosomal dominant pattern with a male-to-female ratio of approximately 3:1.

  • Risk factors

    First-degree relatives of a patient with bicuspid aortic valve, given its autosomal dominant heritability.

  • Pathophysiology

    Abnormal leaflet shear stress from the bicuspid geometry accelerates fibrosis and calcific degeneration, producing valve disease decades before the wear-related calcification of a normal trileaflet valve.

  • Clinical features

    An incidental systolic ejection murmur discovered in adolescence or young adulthood, often the first clue, with gradual progression to severe valve disease by the fifth or sixth decade.

  • Differential diagnosis

    Degenerative (trileaflet) calcific aortic stenosis: similar late-peaking murmur and pulsus tardus, but onset after age 65, no antecedent ejection click, and a trileaflet valve on echocardiography.

  • Diagnosis

    The diagnosis is confirmed by transthoracic echocardiography (TTE) demonstrating bicuspid morphology (two functional cusps, often with an ejection click when pliable) plus formal grading of valve…

  • Management

    Management is determined by the predominant lesion type (stenosis or regurgitation) and its severity, following the same framework as for a trileaflet valve; see aortic-stenosis and aortic-regurgitation for full lesion-specific protocols.

  • Complications

    Aortic dissection, the most feared complication: a 6% lifetime risk, approximately 9 times that of the general population with a trileaflet valve.

  • Prognosis

    Once aortic stenosis becomes severe, the natural history turns unfavorable quickly: 75% of asymptomatic patients die or develop symptoms within 5 years; once symptoms occur, life expectancy is…

  • Prevention

    Screen first-degree relatives of every patient with bicuspid aortic valve using echocardiography, given its autosomal dominant heritability, particularly when the proband also has aortopathy.

Read the whole article

Subscribing to Internal Medicine opens every article, the full question bank and MedBrain, on the web, iPhone and Android.